| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00109-005-0637-5 |
| P698 | PubMed publication ID | 15827759 |
| P2093 | author name string | Seema S Ahuja | |
| Sunil K Ahuja | |||
| Matthias Mack | |||
| William A Kuziel | |||
| Yogeshwar Kalkonde | |||
| Carlos A Estrada | |||
| Marlon P Quinones | |||
| P2860 | cites work | The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 |
| Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells | Q24608200 | ||
| Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 | ||
| Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8 | Q24793032 | ||
| Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice | Q28509805 | ||
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c | Q28588634 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection | Q28594148 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). | Q30307189 | ||
| CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice | Q30891436 | ||
| Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes | Q31017238 | ||
| The chemokine system: redundancy for robust outputs | Q33650445 | ||
| Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease | Q34781971 | ||
| Chemokines and chemokine receptors in rheumatoid arthritis | Q35031896 | ||
| C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
| Pathogenesis of bone and cartilage destruction in rheumatoid arthritis | Q35158472 | ||
| Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization | Q35173616 | ||
| Immunopathogenesis of collagen arthritis. | Q35194784 | ||
| IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints | Q35552036 | ||
| Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid | Q35605220 | ||
| Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? | Q35694207 | ||
| Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains | Q35748862 | ||
| Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. | Q36028645 | ||
| An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model | Q36380336 | ||
| Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model | Q37383845 | ||
| Collagen autoimmunity and arthritis. | Q39534442 | ||
| Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses | Q40427517 | ||
| Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis | Q40643961 | ||
| The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. | Q40674317 | ||
| Collagen arthritis--what can it teach us? | Q40700344 | ||
| Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. | Q40833931 | ||
| Chemokine production by human chondrocytes | Q42477798 | ||
| Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines | Q42492021 | ||
| Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis | Q43607170 | ||
| Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies | Q43607200 | ||
| Protection from pulmonary fibrosis in the absence of CCR2 signaling | Q43760123 | ||
| AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. | Q43760150 | ||
| Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse | Q43974826 | ||
| TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection | Q44308127 | ||
| Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis | Q44928706 | ||
| Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration | Q47652339 | ||
| Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. | Q51830522 | ||
| The chemoattraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5. | Q53388669 | ||
| Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. | Q54001255 | ||
| CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. | Q54020149 | ||
| The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. | Q54540668 | ||
| Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice | Q57019206 | ||
| Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis | Q57306873 | ||
| CC chemokine receptor 5 polymorphism in rheumatoid arthritis | Q63728135 | ||
| Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells | Q71708739 | ||
| CXCR3 and CCR5 ligands in rheumatoid arthritis synovium | Q73352970 | ||
| Susceptibility to collagen-induced arthritis: cytokine-mediated regulation | Q73352994 | ||
| C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome | Q73711980 | ||
| The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF | Q74066265 | ||
| Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram | Q74460278 | ||
| A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses | Q74715421 | ||
| Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis | Q74844694 | ||
| Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases | Q77332357 | ||
| Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis | Q77738063 | ||
| Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis | Q77738646 | ||
| Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression | Q77872967 | ||
| Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen | Q77899668 | ||
| Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes | Q78108584 | ||
| Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy | Q79181133 | ||
| Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice | Q95721029 | ||
| P433 | issue | 9 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 672-681 | |
| P577 | publication date | 2005-04-13 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis | |
| P478 | volume | 83 |
| Q47100328 | A time-course microarray data analysis reveals consistent dysregulated genes and upstream microRNAs in autoantibody-mediated arthritis |
| Q43913450 | CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium |
| Q42113713 | CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury |
| Q40416886 | CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis |
| Q37689783 | CCR5 antagonists: the answer to inflammatory disease? |
| Q36186892 | CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice |
| Q43290133 | CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis |
| Q34051768 | Chemokines and chemokine receptors in arthritis |
| Q64101722 | Early Peritoneal CC Chemokine Production Correlates with Divergent Inflammatory Phenotypes and Susceptibility to Experimental Arthritis in Mice |
| Q34896763 | Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells |
| Q33646334 | Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis |
| Q30438557 | Induction of CCR2-dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q35094676 | MMP-Activated Fluorescence Imaging Detects Early Joint Inflammation in Collagen-Antibody-Induced Arthritis in CC-Chemokine Receptor-2-Null Mice, In-Vivo |
| Q36310750 | Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations |
| Q36324916 | Osteoclast precursors, RANKL/RANK, and immunology |
| Q38083321 | Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012. |
| Q90284320 | Proportion of the CD19-Positive and CD19-Negative Lymphocytes and Monocytes within the Peripheral Blood Mononuclear Cell Set is Characteristic for Rheumatoid Arthritis |
| Q38332567 | Role of myeloid-derived suppressor cells in autoimmune disease |
| Q37658000 | Soya-cerebroside, an extract of Cordyceps militaris, suppresses monocyte migration and prevents cartilage degradation in inflammatory animal models |
| Q38647749 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis |
| Q26797338 | T Cell Migration in Rheumatoid Arthritis |
| Q34344254 | TGF-β type II receptor/MCP-5 axis: at the crossroad between joint and growth plate development |
| Q41945153 | The multiple chemokine-binding bovine herpesvirus 1 glycoprotein G (BHV1gG) inhibits polymorphonuclear cell but not monocyte migration into inflammatory sites. |
| Q43183926 | Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist |
| Q28742993 | Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis |
| Q87450517 | [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation] |
Search more.